Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 236963, 9 pages
http://dx.doi.org/10.1155/2013/236963
Review Article

Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis

Department of Gastroenterology, Shanghai tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China

Received 14 December 2012; Revised 7 March 2013; Accepted 7 March 2013

Academic Editor: Edoardo Giovanni Giannini

Copyright © 2013 Dong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • Yan Zhang, Jie Lu, Weiqi Dai, Fan Wang, Miao Shen, Jing Yang, Rong Zhu, Huawei Zhang, Kan Chen, Ping Cheng, Lei He, Chengfen Wang, Ling Xu, Yingqun Zhou, and Chuanyong Guo, “Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis,” Gastroenterology Research and Practice, vol. 2013, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Anna Hadjihambi, Varun Khetan, and Rajiv Jalan, “Pharmacotherapy for hyperammonemia,” Expert Opinion on Pharmacotherapy, vol. 15, no. 12, pp. 1685–1695, 2014. View at Publisher · View at Google Scholar
  • Yan Zhang, Kan Chen, Weiqi Dai, Yujing Xia, Fan Wang, Miao Shen, Ping Cheng, Chengfen Wang, Jing Yang, Rong Zhu, Huawei Zhang, Jingjing Li, Yuanyuan Zheng, Junshan Wang, Jie Lu, Yingqun Zhou, and Chuanyong Guo, “Combination therapy of bezafibrate and ursodeoxycholic acid for primary biliary cirrhosis: A meta-analysis,” Hepatology Research, 2014. View at Publisher · View at Google Scholar
  • Christian van Delden, “Bacterial biliary tract infections in liver transplant recipients,” Current Opinion in Organ Transplantation, vol. 19, no. 3, pp. 223–228, 2014. View at Publisher · View at Google Scholar
  • N. Kimer, A. Krag, S. Møller, F. Bendtsen, and L. L. Gluud, “Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy,” Alimentary Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Fiona Chautant, Véronique Duhalde, and Christophe Bureau, “Rifaximin and hepatic encephalopathy: Is rifaximin an ideal antibiotic?,” Hepato-Gastro, vol. 21, no. 10, pp. 845–852, 2014. View at Publisher · View at Google Scholar
  • Rong Zhu, Kan Chen, Yuan-Yuan Zheng, Hua-Wei Zhang, Jun-Shan Wang, Yu-Jing Xia, Wei-Qi Dai, Fan Wang, Miao Shen, Ping Cheng, Yan Zhang, Cheng-Fen Wang, Jing Yang, Jing-Jing Li, Jie Lu, Ying-Qun Zhou, and Chuan-Yong Guo, “Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy,” World Journal Of Gastroenterology, vol. 20, no. 47, pp. 18013–18021, 2014. View at Publisher · View at Google Scholar
  • Jamie Potosek, Michael Curry, Mary Buss, and Eva Chittenden, “Integration of Palliative Care in End-Stage Liver Disease and Liver Transplantation,” Journal of Palliative Medicine, vol. 17, no. 11, pp. 1271–1277, 2014. View at Publisher · View at Google Scholar
  • Maria Jover-Cobos, Varun Khetan, and Rajiv Jalan, “Treatment of hyperammonemia in liver failure,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 1, pp. 105–110, 2014. View at Publisher · View at Google Scholar
  • Rong Zhu, Jing Yang, Ling Xu, Weiqi Dai, Fan Wang, Miao Shen, Yan Zhang, Huawei Zhang, Kan Chen, Ping Cheng, Chengfen Wang, Yuanyuan Zheng, Jingjing Li, Jie Lu, Yingqun Zhou, Dong Wu, and Chuanyong Guo, “ Diagnostic Performance of Des- γ -carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis ,” Gastroenterology Research and Practice, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Yan Zhang, Wenxia Lu, Yuqing Zhou, Qin Yin, Yujing Xia, Yingqun Zhou, Jie Lu, Chuanyong Guo, Sainan Li, Lei He, Fan Wang, Kan Chen, Jingjing Li, Tong Liu, Yuanyuan Zheng, and Jianrong Wang, “Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: A meta-analysis,” Drug Design, Development and Therapy, vol. 9, pp. 2757–2766, 2015. View at Publisher · View at Google Scholar
  • G.-Q. Zhu, K.-Q. Shi, S. Huang, L.-R. Wang, Y.-Q. Lin, G.-Q. Huang, Y.-P. Chen, M. Braddock, and M.-H. Zheng, “Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy,” Alimentary Pharmacology & Therapeutics, 2015. View at Publisher · View at Google Scholar
  • Jordi Sanchez-Delgado, and Mireia Miquel, “Papel de la rifaximina en el tratamiento de la encefalopatía hepática,” Gastroenterología y Hepatología, 2015. View at Publisher · View at Google Scholar
  • Jing Yang, Jingjing Li, Weiqi Dai, Fan Wang, Miao Shen, Kan Chen, Ping Cheng, Yan Zhang, Chengfen Wang, Rong Zhu, Huawei Zhang, Yuanyuan Zheng, Junshan Wang, Yujing Xia, Jie Lu, Yingqun Zhou, and Chuanyong Guo, “Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta‑analysis,” Experimental and Therapeutic Medicine, 2015. View at Publisher · View at Google Scholar
  • Huawei Zhang, Chuanyong Guo, Sainan Li, Jing Yang, Yuanyuan Zheng, Jianrong Wang, Wenxia Lu, Yuqing Zhou, Qin Yin, and Rong Zhu, “A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: Evidence from 97 monotherapy and 117 combinations,” Przeglad Gastroenterologiczny, vol. 10, no. 3, pp. 148–155, 2015. View at Publisher · View at Google Scholar
  • Huawei Zhang, Jing Yang, Rong Zhu, Yuanyuan Zheng, Yuqing Zhou, Weiqi Dai, Fan Wang, Kan Chen, Jingjing Li, Chengfen Wang, Sainan Li, Tong Liu, Huerxidan Abudumijiti, Zheng Zhou, Jianrong Wang, Wenxia Lu, Junshan Wang, Yujing Xia, Yingqun Zhou, Jie Lu, and Chuanyong Guo, “Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis,” Drug Design Development And Therapy, vol. 9, pp. 567–574, 2015. View at Publisher · View at Google Scholar
  • Jiang-Feng Ye, and Jian Ju, “Rifaximin for prevention and treatment of hepatic encephalopathy,” World Chinese Journal of Digestology, vol. 23, no. 7, pp. 1090–1096, 2015. View at Publisher · View at Google Scholar
  • Jordi Sanchez-Delgado, and Mireia Miquel, “Role of rifaximin in the treatment of hepatic encephalopathy,” Gastroenterología y Hepatología (English Edition), 2016. View at Publisher · View at Google Scholar
  • Jeffrey D. DellaVolpe, Jeffrey M. Garavaglia, and David T. Huang, “Management of Complications of End-Stage Liver Disease in the Intensive Care Unit,” Journal Of Intensive Care Medicine, vol. 31, no. 2, pp. 94–103, 2016. View at Publisher · View at Google Scholar
  • Damian Piotrowski, and Anna Boroń-Kaczmarska, “Bacterial infections and hepatic encephalopathy in liver cirrhosis–prophylaxis and treatment,” Advances in Medical Sciences, vol. 62, no. 2, pp. 345–356, 2017. View at Publisher · View at Google Scholar